Table 6:
Intrafluid biofilm heterogeneity testing after treatment with tobramycin at concentration levels 25, 50, 100, 200, 400 μg ml−1. 100 independent paths of length 1800 were randomly selected for each concentration level.
| Tobramycin (μg ml−1) | p-value |
|---|---|
| 25 | < 10−16 |
| 50 | < 10−16 |
| 100 | < 10−16 |
| 200 | < 10−16 |
| 400 | < 10−16 |